Previous studies report that Grx is overexpressed in pancreatic ductal carcinoma compared to normal pancreatic tissue and that Grx overexpression increases MCF-7 adenocarcinoma cell resistance to doxorubicin (35, 36). This evidence concerns the gene GLRX and pancreatic ductal adenocarcinoma.